Abstract

Introduction: Although used as an anesthetic drug for decades, ketamine appears to have garnered renewed interest due to its potential therapeutic uses in pain therapy, neurology, and psychiatry. Ketamine undergoes extensive oxidative metabolism by cytochrome P450 (CYP) enzymes. Considerable efforts have been expended to elucidate the ketamine-induced regulation of CYP gene expression. The safety profile of chronic ketamine administration is still unclear. Understanding how ketamine regulates CYP gene expression is clinically meaningful. Areas covered: In this article, the authors provide a brief review of clinical applications of ketamine and its metabolism by CYP enzymes. We discuss the effects of ketamine on the regulation of CYP gene expression, exploring aspects of cytoskeletal remodeling, mitochondrial functions, and calcium homeostasis. Expert opinion: Ketamine may inhibit CYP gene expression through inhibiting calcium signaling, decreasing ATP levels, producing excessive reactive oxygen species, and subsequently perturbing cytoskeletal dynamics. Further research is still needed to avoid possible ketamine–drug interactions during long-term use in the clinic.

Original languageEnglish
Pages (from-to)709-720
Number of pages12
JournalExpert Opinion on Drug Metabolism and Toxicology
Volume14
Issue number7
DOIs
Publication statusPublished - Jul 3 2018

Fingerprint

Ketamine
Gene expression
Cytochrome P-450 Enzyme System
Gene Expression
Metabolism
Calcium
Calcium Signaling
Expert Testimony
Neurology
Therapeutic Uses
Psychiatry
Anesthetics
Reactive Oxygen Species
Homeostasis
Adenosine Triphosphate
Safety
Pain
Research

Keywords

  • ATP
  • calcium
  • cytochrome P450
  • cytoskeleton
  • gene expression
  • Ketamine

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

@article{e7188a4d9e864303a51a036d7bec3601,
title = "Regulation of cytochrome P450 gene expression by ketamine: a review",
abstract = "Introduction: Although used as an anesthetic drug for decades, ketamine appears to have garnered renewed interest due to its potential therapeutic uses in pain therapy, neurology, and psychiatry. Ketamine undergoes extensive oxidative metabolism by cytochrome P450 (CYP) enzymes. Considerable efforts have been expended to elucidate the ketamine-induced regulation of CYP gene expression. The safety profile of chronic ketamine administration is still unclear. Understanding how ketamine regulates CYP gene expression is clinically meaningful. Areas covered: In this article, the authors provide a brief review of clinical applications of ketamine and its metabolism by CYP enzymes. We discuss the effects of ketamine on the regulation of CYP gene expression, exploring aspects of cytoskeletal remodeling, mitochondrial functions, and calcium homeostasis. Expert opinion: Ketamine may inhibit CYP gene expression through inhibiting calcium signaling, decreasing ATP levels, producing excessive reactive oxygen species, and subsequently perturbing cytoskeletal dynamics. Further research is still needed to avoid possible ketamine–drug interactions during long-term use in the clinic.",
keywords = "ATP, calcium, cytochrome P450, cytoskeleton, gene expression, Ketamine",
author = "Chen, {Jui Tai} and Li Wei and Chen, {Ta Liang} and Huang, {Chun Jen} and Chen, {Ruei Ming}",
year = "2018",
month = "7",
day = "3",
doi = "10.1080/17425255.2018.1487397",
language = "English",
volume = "14",
pages = "709--720",
journal = "Expert Opinion on Drug Metabolism and Toxicology",
issn = "1742-5255",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Regulation of cytochrome P450 gene expression by ketamine

T2 - a review

AU - Chen, Jui Tai

AU - Wei, Li

AU - Chen, Ta Liang

AU - Huang, Chun Jen

AU - Chen, Ruei Ming

PY - 2018/7/3

Y1 - 2018/7/3

N2 - Introduction: Although used as an anesthetic drug for decades, ketamine appears to have garnered renewed interest due to its potential therapeutic uses in pain therapy, neurology, and psychiatry. Ketamine undergoes extensive oxidative metabolism by cytochrome P450 (CYP) enzymes. Considerable efforts have been expended to elucidate the ketamine-induced regulation of CYP gene expression. The safety profile of chronic ketamine administration is still unclear. Understanding how ketamine regulates CYP gene expression is clinically meaningful. Areas covered: In this article, the authors provide a brief review of clinical applications of ketamine and its metabolism by CYP enzymes. We discuss the effects of ketamine on the regulation of CYP gene expression, exploring aspects of cytoskeletal remodeling, mitochondrial functions, and calcium homeostasis. Expert opinion: Ketamine may inhibit CYP gene expression through inhibiting calcium signaling, decreasing ATP levels, producing excessive reactive oxygen species, and subsequently perturbing cytoskeletal dynamics. Further research is still needed to avoid possible ketamine–drug interactions during long-term use in the clinic.

AB - Introduction: Although used as an anesthetic drug for decades, ketamine appears to have garnered renewed interest due to its potential therapeutic uses in pain therapy, neurology, and psychiatry. Ketamine undergoes extensive oxidative metabolism by cytochrome P450 (CYP) enzymes. Considerable efforts have been expended to elucidate the ketamine-induced regulation of CYP gene expression. The safety profile of chronic ketamine administration is still unclear. Understanding how ketamine regulates CYP gene expression is clinically meaningful. Areas covered: In this article, the authors provide a brief review of clinical applications of ketamine and its metabolism by CYP enzymes. We discuss the effects of ketamine on the regulation of CYP gene expression, exploring aspects of cytoskeletal remodeling, mitochondrial functions, and calcium homeostasis. Expert opinion: Ketamine may inhibit CYP gene expression through inhibiting calcium signaling, decreasing ATP levels, producing excessive reactive oxygen species, and subsequently perturbing cytoskeletal dynamics. Further research is still needed to avoid possible ketamine–drug interactions during long-term use in the clinic.

KW - ATP

KW - calcium

KW - cytochrome P450

KW - cytoskeleton

KW - gene expression

KW - Ketamine

UR - http://www.scopus.com/inward/record.url?scp=85049412936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049412936&partnerID=8YFLogxK

U2 - 10.1080/17425255.2018.1487397

DO - 10.1080/17425255.2018.1487397

M3 - Review article

VL - 14

SP - 709

EP - 720

JO - Expert Opinion on Drug Metabolism and Toxicology

JF - Expert Opinion on Drug Metabolism and Toxicology

SN - 1742-5255

IS - 7

ER -